Open company graph database — free web & API
Login

Beacle Inc.

株式会社ビークル
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
4
§01

Basic information

BASIC
Head office
14-1 Yoshida Kawaramachi, Sakyo-ku, Kyoto 606-8305, Japan
Chief executive
Yasunori Oda
Capital
50,000,000 JPY
Employees (non-consolidated)
Employees (consolidated)
Start date
2002-08-12
End date
§02

Websites

1 DOMAINS
§03

Business

3
Research, development, manufacturing, and sales of pharmaceuticals, quasi-drugs, reagents, and equipmentDevelopment of pharmaceutical-related technologies (DDS, vaccines, antibody sensors, etc.)Manufacture and sale of research reagents (immunoassay-related products, hepatitis B virus-related products)
§04

Related companies

4 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Osaka University
Shareholder
Okayama University
Shareholder
慶応義塾大学
Shareholder
Kobe University
Shareholder
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

27 EVENTS

Established as a university-originated venture jointly by Okayama University, Kobe University, Osaka University, and Keio UniversitySources

Founded to industrialize Bio-nanocapsule (BNC)Sources

Research institute and headquarters established at Okayama Research Park Incubation CenterSources

Changed to a corporationSources

Company configuration changedSources

Osaka branch openedSources

Osaka branch openedSources

Received Excellence Award at the 4th Bio Business Competition JapanSources

Won the 4th Bio-Business Competition Japan Prize.Sources

Laboratory and Headquarters opened at OkayamaSources

Received University Venture Merit AwardSources

Won the Bio-Venture Originated Universities PrizeSources

Received the Minister of Education, Culture, Sports, Science and Technology Award at the 4th Bio Venture Grand PrixSources

Won the 4th Bio-venture Prize (MEXT)Sources

Manufacturing plant completed at Okayama Research Park Incubation CenterSources

Manufacturing plant completed (Okayama)Sources

Development of anti-cancer DDS drug started.Sources

Successful in in vivo siRNA delivery using our original siRNA carrierSources

in vivo siRNA delivery succeeded with our original delivery systemSources

Launch of our first research reagent Signal BoosterSources

“Signal Booster” as our first research reagent launchedSources

Successful development of protein-internalizing BNC capable of delivering proteins into cellsSources

Succeeded to develop Protein-incorporated BNC for introducing proteins into cellsSources

Headquarters and research institute relocated to KyotoSources

Beacle’s Headquater and Research Laboratory moved to Kyoto.Sources

Adopted for the 2013 NEDO Innovation Commercialization Development ProjectSources

Awarded from NEDO’s GrantSources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑